Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

As more Big Pharma companies have launched direct-to-consumer telehealth platforms, lawmakers have raised concerns they might ...

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Stocks looked set to extend gains on Friday after mostly finishing higher the previous day. The market is getting a lift from ...

This week, Roche RHHBY announced its third-quarter and nine-month results. Sanofi SNY confirmed that it is holding exclusive ...

A key panel of U.S. health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and ...

Housed in a 53′, state-of-the-art, double expandable trailer on wheels, Pfizer School of Science Mobile Experience will travel to select parts of the country throughout 2024 and 2025 to bring the ...

Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the ...

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

About 20% of the working-age Americans in a typical state reported in 2023 that they had some form of arthritis, according to the CDC.

The CDC recommends that immunocompromised people and those age 65 and older should get a second dose of the 2024-2025 COVID ...

These two stocks have moved in different directions this year, but that shouldn't mean much to long-term investors.